Bausch Health Companies Inc. (BHC)
NYSE: BHC · Real-Time Price · USD
5.42
+0.25 (4.84%)
Apr 24, 2025, 11:44 AM EDT - Market open
Bausch Health Companies Revenue
In the year 2024, Bausch Health Companies had annual revenue of $9.63B with 9.91% growth. Bausch Health Companies had revenue of $2.56B in the quarter ending December 31, 2024, with 6.27% growth.
Revenue (ttm)
$9.63B
Revenue Growth
+9.91%
P/S Ratio
0.20
Revenue / Employee
$464,976
Employees
20,700
Market Cap
2.00B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 9.63B | 868.00M | 9.91% |
Dec 31, 2023 | 8.76B | 633.00M | 7.79% |
Dec 31, 2022 | 8.12B | -310.00M | -3.68% |
Dec 31, 2021 | 8.43B | 407.00M | 5.07% |
Dec 31, 2020 | 8.03B | -574.00M | -6.67% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
BHC News
- 2 days ago - Bausch Health Learns Icahn Has 34% Economic Interest in Shares - WSJ
- 2 days ago - Bausch Health says Carl Icahn has exposure to about 34% of company's shares - Reuters
- 2 days ago - Bausch Health Announces Filing of Supplement to Proxy Statement - Accesswire
- 3 days ago - Bausch + Lomb Reports More Than 100 Million Units of Contacts Lenses, Lens Care and Eye Care Materials Collected Through ONE By ONE and Biotrue® Eye Care Recycling Programs - Business Wire
- 6 days ago - U.S. District Court Grants Summary Judgment in Favor of FDA, Salix, and Teva, and Against Norwich - Accesswire
- 9 days ago - Bausch Health Announces Adoption of Shareholder Rights Plan - Accesswire
- 13 days ago - Bausch Health Announces Ortho Dermatologics 2025 ASPIRE HIGHER Scholarship Program - Accesswire
- 15 days ago - Bausch Health, Canada Inc. and the pan-Canadian Pharmaceutical Alliance Sign Letter of Intent for Public Drug Plan Coverage of (Pr)CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris - Accesswire